TP53 and B-cell chronic lymphocytic leukemia: Eighteen out of 100 CLL cases (18%) displayed a mutant TP53 pattern (i.e. high basal level of TP53 without increase upon Nutlin-3 exposure; Figure 1B,C and Additional file 2: Figure S2).